Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Shoutai Pill

Preclinical

PPeking Union Medical College Hospital

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Diminished Ovarian Reserve (DOR)Not yet recruiting

Diminished Ovarian Reserve (DOR)Preclinical

Not yet recruiting

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Diminished Ovarian Reserve (DOR)

NCT07737847

Clinical

Trials by Indication[1]

Diminished Ovarian Reserve (DOR)1 trial

A Study on Biological Subtyping of Reduced Ovarian Reserve With Kidney Essence Deficiency Syndrome Based on Follicular Fluid Metabolomics and Efficacy Prediction of ShouTai Pills

Not yet recruiting·PPeking Union Medical College Hospital·Preclinical·NCT07737847·136 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Shoutai Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Shoutai Pill. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Peking Union Medical College Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: PPeking Union Medical College Hospital

Related News